BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
30 Jan 2015
Change (% chg)

$0.01 (+0.56%)
Prev Close
$1.79
Open
$1.79
Day's High
$1.84
Day's Low
$1.79
Volume
13,265
Avg. Vol
52,884
52-wk High
$3.09
52-wk Low
$1.20

BLRX.OQ

Chart for BLRX.OQ

About

BioLine RX Ltd is an Israel-based company engaged in the development of therapeutics, from preclinical-stage development to advanced clinical trials, for a range of medical needs. Its clinical therapeutic candidates under development consist of BL-1020 that is in Phase II/III clinical trials to improve cognitive function in... (more)

Overall

No Ratios Available.

Financials

  BLRX.OQ Industry Sector
P/E (TTM): -- 188.86 38.54
EPS (TTM): -- -- --
ROI: -- -1.23 18.06
ROE: -- -3.07 18.83
Search Stocks

Novartis buys 12.8 percent stake in BioLineRX in co-development deal

JERUSALEM - Swiss drugmaker Novartis AG bought a 12.8 percent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.

16 Dec 2014

Novartis buys 12.8 pct stake in BioLineRX in co-development deal

JERUSALEM, Dec 16 - Swiss drugmaker Novartis AG bought a 12.8 percent stake in Israeli biopharmaceutical company BioLineRX Ltd as part of a multi-year collaboration deal, BioLineRX said on Tuesday.

16 Dec 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Pechala's Reports
$15.00
Provider: ValuEngine, Inc.
$49.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks